| 2025年年报 | 2025年中报 | 2024年年报 | 2024年中报 | |
|---|---|---|---|---|
| 营业收入(元) | ||||
| 抗肿瘤药(元) | - | - | - | 7,140,937,023.00 |
| 麻醉镇痛药(元) | - | - | - | 1,823,928,376.55 |
| 造影剂(元) | 2,993,172,992.99 | - | 2,749,235,889.45 | 1,374,776,264.86 |
| 代谢和心血管(元) | 2,436,392,215.39 | - | 1,747,836,362.01 | - |
| 免疫和呼吸系统(元) | 861,722,595.87 | - | 776,773,986.08 | - |
| 神经科学(元) | 4,291,837,529.76 | - | 4,288,738,669.03 | - |
| 肿瘤(元) | 16,671,093,834.94 | - | 14,586,573,721.64 | - |
| 销售商品(元) | - | 13,692,712,352.71 | - | - |
| 许可收入(元) | - | 1,991,095,361.98 | - | - |
| 其他(元) | 759,229,178.73 | 77,385,914.21 | 860,423,837.85 | 3,261,092,450.36 |
| 营业成本(元) | ||||
| 抗肿瘤药(元) | - | - | - | 550,407,024.13 |
| 麻醉镇痛药(元) | - | - | - | 283,557,559.39 |
| 造影剂(元) | 1,234,649,640.64 | - | 1,086,932,490.01 | 534,138,608.28 |
| 代谢和心血管(元) | 641,066,621.70 | - | 408,890,715.11 | - |
| 免疫和呼吸系统(元) | 132,569,750.98 | - | 126,671,794.63 | - |
| 神经科学(元) | 741,131,143.25 | - | 653,514,254.18 | - |
| 肿瘤(元) | 1,086,375,839.14 | - | 1,084,203,084.34 | - |
| 销售商品(元) | - | 2,087,582,736.74 | - | - |
| 许可收入(元) | - | - | - | - |
| 其他(元) | 348,098,104.99 | 27,379,432.44 | 376,668,636.71 | 505,200,463.58 |
| 毛利(元) | ||||
| 抗肿瘤药(元) | - | - | - | 6,590,529,998.87 |
| 麻醉镇痛药(元) | - | - | - | 1,540,370,817.16 |
| 造影剂(元) | 1,758,523,352.35 | - | 1,662,303,399.44 | 840,637,656.58 |
| 代谢和心血管(元) | 1,795,325,593.69 | - | 1,338,945,646.90 | - |
| 免疫和呼吸系统(元) | 729,152,844.89 | - | 650,102,191.45 | - |
| 神经科学(元) | 3,550,706,386.51 | - | 3,635,224,414.85 | - |
| 肿瘤(元) | 15,584,717,995.80 | - | 13,502,370,637.30 | - |
| 销售商品(元) | - | 11,605,129,615.97 | - | - |
| 许可收入(元) | - | 1,991,095,361.98 | - | - |
| 其他(元) | 411,131,073.74 | 50,006,481.77 | 483,755,201.14 | 2,755,891,986.78 |
| 毛利率(%) | ||||
| 抗肿瘤药(%) | - | - | - | 92.29 |
| 麻醉镇痛药(%) | - | - | - | 84.45 |
| 造影剂(%) | 58.75 | - | 60.46 | 61.15 |
| 代谢和心血管(%) | 73.69 | - | 76.61 | - |
| 免疫和呼吸系统(%) | 84.62 | - | 83.69 | - |
| 神经科学(%) | 82.73 | - | 84.76 | - |
| 肿瘤(%) | 93.48 | - | 92.57 | - |
| 销售商品(%) | - | 84.75 | - | - |
| 许可收入(%) | - | - | - | - |
| 其他(%) | 54.15 | 64.62 | 56.22 | 84.51 |
| 收入构成(%) | ||||
| 抗肿瘤药(%) | - | - | - | 52.50 |
| 麻醉镇痛药(%) | - | - | - | 13.41 |
| 造影剂(%) | 10.68 | - | 10.99 | 10.11 |
| 代谢和心血管(%) | 8.70 | - | 6.99 | - |
| 免疫和呼吸系统(%) | 3.08 | - | 3.11 | - |
| 神经科学(%) | 15.32 | - | 17.15 | - |
| 肿瘤(%) | 59.51 | - | 58.32 | - |
| 销售商品(%) | - | 86.88 | - | - |
| 许可收入(%) | - | 12.63 | - | - |
| 其他(%) | 2.71 | 0.49 | 3.44 | 23.98 |
| 毛利构成(%) | ||||
| 抗肿瘤药(%) | - | - | - | 56.20 |
| 麻醉镇痛药(%) | - | - | - | 13.13 |
| 造影剂(%) | 7.38 | - | 7.81 | 7.17 |
| 代谢和心血管(%) | 7.53 | - | 6.29 | - |
| 免疫和呼吸系统(%) | 3.06 | - | 3.06 | - |
| 神经科学(%) | 14.90 | - | 17.09 | - |
| 肿瘤(%) | 65.40 | - | 63.47 | - |
| 销售商品(%) | - | 85.04 | - | - |
| 许可收入(%) | - | 14.59 | - | - |
| 其他(%) | 1.73 | 0.37 | 2.27 | 23.50 |